Patients who use semaglutide for weight loss, like Ozempic, are more likely to continue the medication if they perceive it as effective, even when facing unpleasant side effects, according to Rutgers Health researchers.

Their study, published in Journal of Medical Internet Research, found perceived effectiveness – reductions in weight, appetite or food cravings – was the strongest predictor of satisfaction and intention to continue treatment, regardless of side effects.

Treatment numbers rose over the 2010s as the opioid crisis became prominent and also included increases in buprenorphine, an easier to access medication

A massive study with over 6 million participants reveals genetic clusters behind 14 psychiatric disorders, opening the door to better diagnoses and treatments.